» Authors » Devasahayam Jesudas Christopher

Devasahayam Jesudas Christopher

Explore the profile of Devasahayam Jesudas Christopher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 908
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas A, Thangakunam B, Kodiatte T, Christopher D
Respirol Case Rep . 2025 Feb; 13(2):e70111. PMID: 39959461
A 56-year-old man presented with right-sided pleuritic chest pain and intermittent cough for 4 months, with a background history of well-controlled asthma and allergic rhinitis. Chest radiographs revealed right-sided pleural...
2.
Moitra S, Liyanage G, Tonkin-Crine S, Powell N, Jani Y, Dasanayake D, et al.
Clin Exp Allergy . 2025 Jan; PMID: 39854040
Data regarding Penicillin allergy labels (PALs) from India and Sri Lanka are sparse. Emerging data suggests that the proportion of patients declaring an unverified PAL in secondary care in India...
3.
Weber S, Wolf P, Wetzstein N, Kupper-Tetzel C, Vehreschild M, Suarez I, et al.
Open Forum Infect Dis . 2024 Dec; 11(12):ofae651. PMID: 39691283
Background: There is limited evidence on point-of-care ultrasound for tuberculosis (TB), but studies suggest high sensitivity, especially for lung ultrasound (LUS). However, insufficient data are available on specificity of the...
4.
Derendinger B, Mochizuki T, Marcelo D, Shankar D, Mangeni W, Nguyen H, et al.
Am J Respir Crit Care Med . 2024 Dec; 211(3):499-506. PMID: 39642368
C-reactive protein (CRP)-based tuberculosis (TB) screening is recommended for people with HIV. However, its performance among people without HIV and in diverse settings is unknown. In a multicountry study, we...
5.
Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, et al.
Clin Infect Dis . 2024 Jul; 79(4):1034-1038. PMID: 38991034
In this prospective cohort of 2006 individuals with drug-susceptible tuberculosis in India, 18% had unfavorable treatment outcomes (4.7% treatment failure, 2.5% recurrent infection, 4.1% death, 6.8% loss to follow-up) over...
6.
Derendinger B, Mochizuki T, Marcelo D, Shankar D, Mangeni W, Nguyen H, et al.
medRxiv . 2024 May; PMID: 38712173
Rationale: C-reactive protein (CRP)-based tuberculosis (TB) screening is recommended for people with HIV (PWH). However, its performance among people without HIV and in diverse settings is unknown. Objectives: In a...
7.
8.
Christopher D, Isaac B, John F, Shankar D, Samuel P, Gupta R, et al.
PLOS Glob Public Health . 2024 Feb; 4(2):e0002884. PMID: 38300923
After recovery from COVID-19, there is data to suggest potential long-term pulmonary sequelae and associated impairment of functional capacity. This cross-sectional study was designed to assess the impact on respiratory...
9.
Gupta-Wright A, Ha H, Abdulgadar S, Crowder R, Emmanuel J, Mukwatamundu J, et al.
Lancet Glob Health . 2024 Jan; 12(2):e226-e234. PMID: 38245113
Background: Non-sputum-based triage tests for tuberculosis are a priority for ending tuberculosis. We aimed to evaluate the diagnostic accuracy of the late-prototype Xpert MTB Host Response (Xpert HR) blood-based assay....
10.
Krishna M, Liyanage G, Shrestha R, Jordan R, Christopher D
Lancet Reg Health Southeast Asia . 2024 Jan; 20:100320. PMID: 38234704
No abstract available.